Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...
Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to ...
Dec 3 (Reuters) - Excelsior Sciences said on Wednesday it has raised $95 million to develop technology that uses machines and artificial intelligence to accelerate the development and testing of small ...
Every great leap in history started with a single, urgent need. Now AI is emerging as the next great engine of invention, transforming the future of medicine faster than ever imagined. From landing on ...
One of the most complex issues in health care is the development and commercialization of treatments and cures for rare and orphan diseases — those for which no drug has been developed because its ...
OBI-902 is the first ADC utilizing OBI’s proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia, and other serious risks, the Food and Drug ...
To date, the U.S. has conducted airstrikes against 14 boats in the Caribbean Sea and Pacific Ocean, killing at least 57 alleged drug smugglers. “We going to kill, you know,” President Trump declared. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback